4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000239
EVP, Chief Development Officer sold 57,900 shares at $65.24 ($3,777,668)
- EVP, Chief Development Officer acquired 57,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Geary Richard S · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +57,900 | $53.77 | $3,113,283 | 137,557 | D |
| 2025-09-30 | Sale : show line 2 in the form 10b5-1 | −57,900 | $65.24 | $3,777,668 | 79,657 | D |
| Open-market sales · 57,900 sh · avg $65.24 · $3,777,668 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −57,900 | 0 | D |
Loading xslF345X05/edgardoc.xml…